scorecard
  1. Home
  2. stock market
  3. MORGAN STANLEY: Bad news is coming for these 3 stocks

MORGAN STANLEY: Bad news is coming for these 3 stocks

Las Vegas Sands

MORGAN STANLEY: Bad news is coming for these 3 stocks

Myriad Genetics

Myriad Genetics

Ticker:
MYGN

Primary Sector:
Healthcare

Current Stock Price:
$34.32

High/Base/Low Price Projection:
$49/$23/$8

Morgan Stanley's take: "Myriad is now transitioning to a more comprehensive 25 gene panel, myRisk, which tests for hereditary risk of various cancers. Discussions with insurance payors suggest myRisk is meeting resistance for coverage as payors worry about the lack of data proving clinical utility for broad genomic testing and costs."

Parker Hannifin

Parker Hannifin

Ticker:
PH

Primary Sector:
Discretionary/Industrials

Current Stock Price:
$113.21

High/Base/Low Price Projection:
$170/$125/$69

Morgan Stanley's take: "Parker is the purest play on global IP growth to be found in the Machinery group, but uncertainty in the ROW outlook makes material acceleration less likely."

For some more stocks you might want to avoid ...

For some more stocks you might want to avoid ...

Popular Right Now




Advertisement